Prevention and treatment of contrast-induced nephropathy: several problems and current understanding

doi:10.3877/cma.j.issn.2095-3216.2013.02.003

Abstract

Abstract:

With the continuous growth of radiological procedures in diagnosis and interventional therapy, contrast-induced nephropathy (CIN) has gradually become the third leading cause of hospitalacquired acute kidney injury, which is also significantly associated with the increasing long-term mortality and morbidity. Up to the present, there are still no effective therapies for CIN. So prevention of CIN is of great importance. In this review, we mainly introduced the current cognition of CIN, and discussed several problems on the prevention and treatment of it.

Key words: Contrast-induced nephropathy, Prevention, Treatment

Li GONG, Lin LIU. Prevention and treatment of contrast-induced nephropathy: several problems and current understanding[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2013, 02(02): 64-69.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2013.02.003

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2013/V02/I02/64

References 42

1	Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis [J]. JAMA, 1996, 275(19):1489-1494.
2	Perrin T, Descombes E, Cook S. Contrast-induced nephropathy in invasive cardiology [J]. Swiss Med Wkly, 2012, 142: w13608.
3	Kitajima K, Maeda T, Watanabe S, et al. Recent issues in contrastinduced nephropathy [J]. Int J Urol, 2011, 18(10): 686-690.
4	Lencioni R, Fattori R, Morana G, et al. Contrast-induced nephropathy in patients undergoing computed tomography(CONNECT) - a clinical problem in daily practice? A multicenter observational study [J]. Acta Radiol, 2010, 51(7): 741-750.
5	Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR)[J]. Eur Radiol, 1999, 9(8): 1602-1613.
6	Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines [J]. Eur Radiol, 2011, 21(12): 2527-2541.
7	Weisbord SD, Chen H, Stone RA, et al. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography [J]. J Am Soc Nephrol, 2006, 17(10): 2871-2877.
8	Solomon RJ, Mehran R, Natarajan MK, et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? [J].Clin J Am Soc Nephrol, 2009, 4(7): 1162-1169.
9	Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury [J]. Crit Care, 2007, 11(2): R31.
10	Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury [J]. J Am Soc Nephrol, 2009, 20(3): 672-679.
11	Adiyanti SS , Loho T. Acute Kidney Injury (AKI) biomarker [J].Acta Med Indones, 2012, 44(3): 246-255.
12	Alharazy SM, Kong N, Saidin R, et al. Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C are early Biomarkers of Contrast-Induced Nephropathy After Coronary Angiography in Patients With Chronic Kidney Disease [J].Angiology, 2013, Epub ahead of print.
13	Manabe K, Kamihata H, Motohiro M, et al. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury [J]. Eur J Clin Invest, 2012,42(5): 557-563.
14	Vaidya VS, Waikar SS, Ferguson MA, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans [J]. Clin Transl Sci, 2008, 1(3): 200-208.
15	Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and metaanalysis [J]. Am J Kidney Dis, 2009, 54(6): 1012-1024.
16	Briguori C, Visconti G, Rivera NV, et al. Cystatin C and contrastinduced acute kidney injury [J]. Circulation, 2010, 121(19): 2117-2122.
17	Vanmassenhove J, Vanholder R, Nagler E, et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an indepth review of the literature [J]. Nephrol Dial Transplant, 2013,28(2): 254-273.
18	Rundback JH, Nahl D, Yoo V. Contrast-induced nephropathy [J].J Vasc Surg, 2011, 54(2): 575-579.
19	Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation [J]. J Am Coll Cardiol, 2004, 44(7): 1393-1399.
20	Brown JR, Malenka DJ, DeVries JT, et al. Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry [J]. Catheter Cardiovasc Interv, 2008, 72(3): 347-354.
21	Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial.The Iohexol Cooperative Study [J]. Kidney Int, 1995, 47(1): 254-261.
22	Heinrich MC, Haberle L, Muller V, et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials [J].Radiology, 2009, 250(1): 68-86.
23	Alamartine E, Phayphet M, Thibaudin D, et al. Contrast mediuminduced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations [J]. Eur J Intern Med, 2003, 14(7): 426-431.
24	Mitchell AM, Jones AE, Tumlin JA, et al. Incidence of contrastinduced nephropathy after contrast-enhanced computed tomography in the outpatient setting [J]. Clin J Am Soc Nephrol,2010, 5(1): 4-9.
25	Mueller C. Prevention of contrast-induced nephropathy with volume supplementation [J]. Kidney Int, 2006, Suppl 100: S16-S19.
26	Kunadian V, Zaman A, Spyridopoulos I, et al. Sodium bicarbonate for the prevention of contrast induced nephropathy: a metaanalysis of published clinical trials [J]. Eur J Radiol, 2011, 79(1):48-55.
27	Klima T, Christ A, Marana I, et al. Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial[J]. Eur Heart J. 2012,33(16): 2071-2079.
28	Stacul F, Adam A, Becker CR, et al. Strategies to reduce the risk of contrast-induced nephropathy [J]. Am J Cardiol, 2006, 98(6A):59K-77K.
29	Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis:effectiveness of drugs for preventing contrast-induced nephropathy [J]. Ann Intern Med, 2008, 148(4): 284-294.
30	Hoffmann U, Fischereder M, Kruger B, et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable [J]. J Am Soc Nephrol, 2004,15(2): 407-410.
31	Alioglu E, Saygi S, Turk U, et al. N-Acetylcysteine in Preventing Contrast-Induced Nephropathy Assessed by Cystatin C [J].Cardiovasc Ther, 2013, 31(3): 168-173.
32	Kini AS, Mitre CA, Kim M, et al. A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam [J]. Catheter Cardiovasc Interv, 2002, 55(2): 169-173.
33	Weisz G, Filby SJ, Cohen MG, et al. Safety and performance of targeted renal therapy: the Be-RITe! Registry [J]. J Endovasc Ther, 2009, 16(1): 1-12.
34	Sharyo S, Yokota-Ikeda N, Mori M, et al. Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway [J]. Kidney Int, 2008, 74(5): 577-584.
35	Khanal S, Attallah N, Smith DE, et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions [J]. Am J Med, 2005, 118(8): 843-849.
36	Patti G, Nusca A, Chello M, et al. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention [J]. Am J Cardiol, 2008, 101(3): 279-285.
37	Jo SH, Koo BK, Park JS, et al. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study [J]. Am Heart J, 2008, 155(3): 499 e491- e498.
38	Toso A, Maioli M, Leoncini M, et al. Usefulness of atorvastatin(80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease [J]. Am J Cardiol, 2010, 105(3): 288-292.
39	Sadat U. Contrast-induced nephropathy: do statins offer protection? [J]. Curr Opin Cardiol, 2011, 26(4): 334-337.
40	Zhang L, Lu Y, Wu B, et al. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials [J]. Int J Clin Pract, 2011, 65(5): 624-630.
41	Cruz DN, Goh CY, Marenzi G, et al. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review [J]. Am J Med, 2012, 125(1): 66-78 e63.
42	Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration [J]. N Engl J Med, 2003, 349(14): 1333-1340.

[1]	Baicheng Yi, Xuguang Li, Rongrong Wang, Xinxuan Wang. Treatment of calcified root canals in upper anterior teeth using digital 3D-printing guides：A clinical report of two cases [J]. Chinese Journal of Stomatological Research(Electronic Edition), 2024, 18(06): 385-390.
[2]	Huazhi Li, Guang Cao, Diangang Liu, Yajing Zhang. Clinical comparison of descending hepatectomy with different approaches for primary hepatocellular carcinoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 52-55.
[3]	Hao Chen, Meng Wang. Advances in clinicopathological features and treatment options of sig-ring cell carcinoma of the stomach [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 108-111.
[4]	Yuefang Xu, Wang Liu, Miaotian Zeng, Yushu Guo. Clinical efficacy of polymyxin B and polymyxin E in the treatment of surgical multi-drug resistant infections Security analysis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 700-703.
[5]	Zhipeng Jiang, Keli Zhong, Shuang Chen. Prevention and management of abdominal hypertension and abdominal compartment syndrome after complex abdominal wall hernia surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 612-615.
[6]	Xuehu Wang, Yu Zhao. The prevention and treatment of vascular injury complications in complicated abdominal wall hernia surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 616-619.
[7]	Yifan Li, Diwen Zhu, Weixin Ren, Yingjun Bao, Junpeng Gu, Haixiao Zhang, Gengfei Cao, Weizheng Ji. Role of serum GP73 level in the evaluation of TACE efficacy for primary liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 825-830.
[8]	of Organ Transplantation of Chinese Medical Association Branch. Chinese practice guidelines for diagnosis and treatment of ischemic-type biliary lesion after liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 739-748.
[9]	Qiusheng Wang. Diagnosis and treatment strategy for benign biliary diseases [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 779-782.
[10]	Anti-Cancer Association China, Committee of Colorectal Cancer CACA the. CACA guidelines for holistic integrative management of anal cancer （2024 Edition） [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 441-449.
[11]	Xuefeng Zhou, Zheyi Dong, Zhe Feng, Guangyan Cai, Xiangmei Chen. Formulation protocol of guidelines for diagnosis and treatment of diabetic kidney disease with integrated traditional Chinese and Western medicine [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 301-305.
[12]	Bin Shi, Yuan Si. Effect of Yiqiheluo formula combined with valsartan in the treatment of IgA nephropathy with deficiency of both qi and yin plus blood stasis syndrome [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 306-312.
[13]	Wenkai Guo, Pengcheng Ji, Jingru Bi, Yuansheng Xie. Ten treatment measures for IgA nephropathy [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 327-333.
[14]	Xuan Tie, Xiaole Su, Lihua Wang. Progress of research on the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 345-351.
[15]	Tianyu Wu, Zixuan Liu, Puxin Yang, Siming Jia, Kai Ding, Xiaodong Cheng, Yonglong Li, Wei Chen, Hongzhi Lyu, Qi Zhang. Progress in Conservative Treatment of Lumbar Disc Herniation [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2024, 10(06): 379-384.

Please choose a citation manager

Content to export